CN111529440A - Preparation method of acne-removing emulsion - Google Patents
Preparation method of acne-removing emulsion Download PDFInfo
- Publication number
- CN111529440A CN111529440A CN202010323892.4A CN202010323892A CN111529440A CN 111529440 A CN111529440 A CN 111529440A CN 202010323892 A CN202010323892 A CN 202010323892A CN 111529440 A CN111529440 A CN 111529440A
- Authority
- CN
- China
- Prior art keywords
- phase matrix
- preparation
- stirring
- humectant
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 18
- 206010000496 acne Diseases 0.000 title claims abstract description 18
- 239000011159 matrix material Substances 0.000 claims abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000003756 stirring Methods 0.000 claims abstract description 23
- 239000003906 humectant Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 239000012071 phase Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical group OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims description 4
- 229940116229 borneol Drugs 0.000 claims description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
- 229960002216 methylparaben Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003961 penetration enhancing agent Substances 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 3
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 3
- 239000004166 Lanolin Substances 0.000 claims description 3
- 239000004264 Petrolatum Substances 0.000 claims description 3
- 229940039697 alkanna tinctoria root extract Drugs 0.000 claims description 3
- 229940069638 aloe vera leaf extract Drugs 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 229940039717 lanolin Drugs 0.000 claims description 3
- 235000019388 lanolin Nutrition 0.000 claims description 3
- 229960003639 laurocapram Drugs 0.000 claims description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical group CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 3
- 229940066842 petrolatum Drugs 0.000 claims description 3
- 235000019271 petrolatum Nutrition 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- -1 polydimethylsiloxane Polymers 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 claims description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000005325 percolation Methods 0.000 claims description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000001804 emulsifying effect Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 17
- 239000001963 growth medium Substances 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 230000001815 facial effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 241000186427 Cutibacterium acnes Species 0.000 description 5
- 229940055019 propionibacterium acne Drugs 0.000 description 5
- 206010070834 Sensitisation Diseases 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000003255 anti-acne Effects 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000003278 haem Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000186892 Aloe vera Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000002604 borneol group Chemical group 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a preparation method of an acne-removing emulsion. The method comprises the steps of 1) heating and stirring a water phase matrix and an oil phase matrix to a molten state; step 2) adding the oil phase matrix into the water phase matrix, and emulsifying at a certain rotating speed; and 3) adding a skin conditioner and a humectant, and stirring and mixing uniformly. The method disclosed by the invention is simple in production process, mild in preparation conditions, free of damage to natural active ingredients, high in stability, safe, free of side effects and remarkable in acne removing effect.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a preparation method of an acne-removing emulsion.
Background
The emulsion cosmetic is a product which is prepared from an oily raw material and a water-based raw material under the action of a surfactant and has a light yellow to yellowish brown appearance. It is the most common type of skin care products, and cream, honey, milk and the like belong to emulsion products.
Emulsion products can be classified into two types, i.e., water-in-oil type and oil-in-water type, depending on the emulsification properties. Wherein the continuous part in the water-in-oil type product is oily raw material, and the water-based raw material is dispersed in the oily raw material in the form of very small droplets to form an oil-water dispersion system which is greasy and suitable for people with dry skin; the continuous part of the oil-in-water type product is an aqueous raw material, and the oily raw material is dispersed in the aqueous raw material in small liquid drops to form an oil-water dispersion system which is fresh and not greasy and is suitable for people with oily and neutral skin. Cosmetic enterprises often add proper functional or functional substances into basic substances of emulsion products to form cosmetics with various special effects such as whitening, freckle removing, sun protection and the like.
Emulsions are thermodynamically unstable. When the net reduction in interfacial area occurs, the droplets will rearrange from droplet morphology into two volumes of liquid, which is energetically favorable. Emulsion preparation is established by depending on experience for a long time, gradually fills and perfects the theory, and moves to the production guided by the theory. But in practice it still depends on the experience of the operator. Until now, experts who study and produce emulsified products still admit the importance of experience because there are many factors involved in the preparation of emulsions, and there is no theory that can quantitatively guide the emulsification operation, and even experienced operators have difficulty in ensuring that each batch is well emulsified; and the cosmetic emulsion is rich in a large amount of functional natural ingredients, and the natural ingredients can be damaged by the temperature, the emulsifying time and the stirring condition of the production process.
Therefore, a preparation method of the acne-removing emulsion with simple production process and mild preparation conditions without damaging natural active ingredients is needed in the prior art.
Disclosure of Invention
The invention aims to provide a preparation method of an acne-removing emulsion, which at least alleviates one of the technical problems in the prior art.
In order to achieve the purpose, the invention adopts the following technical scheme:
a preparation method of an acne-removing emulsion is characterized by comprising the following steps:
step 1) mixing a solvent, a humectant, a penetration enhancer, borneol, a red sage root extracting solution and a alkanna tinctoria root extract according to a certain proportion, stirring and heating to prepare a water phase matrix;
step 2) mixing the humectant, the lubricant and the emulsifier according to a certain proportion, stirring and heating to prepare an oil phase matrix;
step 3) slowly adding the oil phase matrix into the water phase matrix, and homogenizing at a certain rotating speed; adding xanthan gum solution with the final concentration of 5% (w/w), and continuously stirring;
step 4), adding the aloe vera leaf extract and the humectant into the mixture after passing through a high-pressure homogenizer, and stirring and mixing the mixture uniformly;
step 5) adding the antimicrobial agent to the final emulsion.
Preferably, the step 1) is that the aqueous phase matrix is stirred and heated to 60-100 ℃, and the temperature is kept for 15-25 minutes.
Preferably, the step 2) is to stir the oil phase matrix to raise the temperature to 60-100 ℃ and keep the temperature for 2-10 minutes.
Preferably, the step 3) is to slowly add the oil phase matrix into the water phase matrix, and homogenize at a certain rotation speed of 9500-11000rpm for 1-3 minutes; 5% xanthan gum solution was added and stirring was continued for 3-5 minutes at 12000-14000 rpm.
Preferably, the adding speed of slowly adding the oil phase matrix into the water phase matrix is 3-10kg/min, and the adding and stirring speed is 45-55 rpm.
Preferably, step 4) is carried out by three high-pressure homogenizers with two stages, the pressure being set at 300/30 bar.
Preferably, the temperature in the step 4) is reduced to 30-50 ℃, and the aloe barbadensis leaf extract and the humectant are added and stirred and mixed evenly.
Preferably, the method also comprises the following steps: soaking target Chinese medicinal materials in solvent; adding the wetted medicinal materials into a solvent for soaking for 24 hours; percolating the soaked Chinese medicinal materials at a percolation rate of 50-250 mL/min/kg; collecting percolate, vacuum concentrating and drying to obtain extract; wherein, the solvent is water, ethanol or a solution of the water and the ethanol mixed according to different proportions.
Preferably, the humectant in step 4) is 1, 2-ethanediol.
Preferably, the antimicrobial agent is 0.1% (w/w) methylparaben.
Preferably, in the step 1), the solvent in the water phase matrix is water and ethanol, the humectant is 1, 3-propylene glycol and glycerol, the freshener is borneol, the penetration enhancer is laurocapram, the humectant in the oil phase matrix is petrolatum, lanolin and sodium stearyl glutamate, the lubricant is polydimethylsiloxane, and the emulsifier is cetostearyl alcohol.
More preferably, the final ethanol content is 5% (w/w).
The invention has the beneficial technical effects that:
1. the preparation method provided by the invention is simple in process flow and easy for large-scale production.
2. The emulsion particles produced by the preparation method of the invention are in a sphere-like shape, and the particle diameter is smaller; the emulsion has high stability and is not easy to separate.
3. The emulsion produced by the preparation method has obvious bacteriostatic effect and can obviously improve the damaged skin of the acne patient.
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by manufacturers, and are all conventional products available on the market.
Example 1 preparation of an anti-acne cream according to the invention
Formula (the following are w/w):
the process comprises the following steps:
step 1) mixing the water, the glycerol, the salvia miltiorrhiza extract, the 1, 3-propylene glycol, the ethanol, the borneol, the laurocapram, the methylparaben and the alkanna tinctoria root extract according to the proportion, stirring and heating to 85 ℃, and keeping the temperature for 20 minutes;
step 2) mixing petrolatum, lanolin, polydimethylsiloxane, cetostearyl alcohol and sodium stearyl glutamate according to a certain proportion, stirring and heating to 85 ℃, and keeping the temperature for 5 minutes;
step 3) adding the oil phase matrix into the water phase matrix, wherein the adding speed is 3-10kg/min, the adding stirring rotating speed is 45-55rpm, and emulsifying for 1 minute at the rotating speed of 10000; adding a xanthan gum solution with the final concentration of 5% (w/w) and stirring for 4 minutes at 13000 rpm;
step 4), passing through a three-time two-stage high-pressure homogenizer, wherein the pressure is set to be 300/30 bar; cooling to 30-50 deg.C, adding Aloe Barbadensis Miller leaf extract and 1, 2-ethylene glycol, and stirring;
step 5) add 0.1% methylparaben to the final emulsion.
EXAMPLE 2 measurement of particle size and morphology of emulsion
The emulsion produced by the preparation method is diluted by 50 times by adding distilled water, a proper amount of the emulsion is uniformly coated on a glass slide, the shape of the emulsion is observed by adjusting the magnification of an optical microscope, and the particles in the emulsion are in a sphere-like shape and have the diameter of 30-100 mu m.
EXAMPLE 3 emulsion stability experiment
The emulsion produced by the preparation method is put into a 10cm centrifuge tube, and is centrifuged at the speed of 3750rpm for 5 hours, so that the emulsion is not layered. Each set of 3 replicates.
Example 4 Heat and Cold resistance test
The product is stored in a constant temperature and humidity incubator at 40 ℃ for 48 hours and then taken out, and the oil-water separation phenomenon is observed after the room temperature is recovered; and (3) taking out the emulsion after being placed in a refrigerator at the temperature of-8 ℃ for 48 hours, and observing the oil-water separation phenomenon after the room temperature is recovered, wherein the emulsion has no layering phenomenon. Each set of 3 replicates.
EXAMPLE 5 Rabbit skin Single dose toxicity test
The method comprises the following steps: selecting 60 New Zealand rabbits, and randomly dividing the rabbits into 6 groups: the whole skin blank control group, the whole skin matrix control group, the whole skin administration group, the damaged skin blank control group, the damaged skin matrix control group and the damaged skin administration group, wherein 6 rabbits (female and male halves) are applied to each group at an administration dose of 15g cream/rabbit (6.0g crude drug/rabbit) (maximum administration dose and maximum drug concentration), and the skin is applied and administered 3 times every day at intervals of 4h (the blank control group is given with physiological saline with the same volume, and the matrix control group is given with matrix with the same volume). After administration, the toxic reaction was observed for 28 consecutive days, and body weight, hematology, blood biochemistry and other indicators were measured.
After administration, no obvious abnormality was observed in the rabbits of the intact skin group and the damaged skin group, and no death occurred in the animals. No obvious influence is seen on the weight of each group of rabbits after administration and the weight increase. After the observation is finished, the rabbits are subjected to gross observation, and the skin and the main organs of the administration part of each group of rabbits have no obvious abnormality. After 24 hours of administration, the hematology and blood biochemistry indexes of each group of rabbits have no obvious influence.
Under the experimental condition, the maximum administration area and the maximum concentration (0.4g crude drug/g cream) of the skin smearing administration for three times within 24 hours have no obvious influence on the rabbits.
Example 6 active skin allergy test
The method comprises the following steps: 120 guinea pigs were selected for this study and randomized into 4 groups: the vehicle control group, the administration group-1 group, the administration group-2 group, the positive control group, and 30 guinea pigs (male and female halves) in each group were subjected to the guinea pig active systemic anaphylaxis test. The dose of the group-1 was 0.3g cream/body (0.12g crude drug/body) (maximum drug concentration), the dose of the group-2 was 0.3g cream/body (0.06g crude drug/body) (clinical drug concentration), the positive control group was administered 0.2ml of 1% 1-chloro-2, 4-dinitrobenzene, and the matrix control group was administered the same amount of matrix. Sensitization administration was performed on days 0, 7, 14, and 21, and priming administration was performed 21 days after the last sensitization, each time 0.3 g/body (0.2 ml of 0.1% 1-chloro-2, 4-dinitrobenzene was administered to the positive control group), and the skin was sufficiently contacted for 6 hours.
During sensitization administration, the substrate control group, the administration group-1 group and the administration group-2 group were applied to the skin for 3 times of sensitization administration, and no erythema or edema symptoms occurred in each animal. After the priming, the incidence of skin sensitization to guinea pigs was 0% within 168 hours after the priming of the vehicle control group, the administration group-1, and the administration group-2, and the mice were judged to have no skin allergy.
No obvious skin allergic reaction is observed in the matrix control group, the administration group-1 group and the administration group-2 group of the administration group.
Example 7 study of bacteriostatic Activity
Strain:
propionibacterium acnes standard strain ATCC1I827 and Staphylococcus aureus standard strain ATCC 100817.
Reagent:
acne propionibacterium acnes culture medium; brain heart infusion culture medium; culture medium of staphylococcus aureus beef extract
The culture medium is prepared by a conventional method, and the pH value is adjusted to 7.1-7.2. Sealing the culture medium in a conical flask, sterilizing in a sterilizing pot at 121 deg.C for 30min, cooling, and storing in a refrigerator at 4 deg.C.
The preparation of the bacterial suspension comprises the steps of respectively inoculating standard strains for culture and enrichment, culturing for 24h under the conventional culture conditions (culturing propionibacterium acnes for 48h by using an anaerobic glove box), diluting the absorbed bacterial liquid by using a culture medium to adjust the concentration to 0.5 McRIBU unit (about 1.5X108CFU/mL), continuously diluting the bacterial suspension by using the culture medium, and adjusting the concentration to 1X 105-106 CFU/mL by using a McRIBU turbidimeter for later use.
Determination of zone of inhibition
Respectively taking the bacterial suspensions under the aseptic operation condition, and uniformly coating the bacterial suspensions on a culture medium by using a coating rod. And lightly placing the oxford cup on the surface of the solidified culture medium by using sterile forceps, and lightly pressing the oxford cup to ensure good contact. And (3) sucking the test solution into an Oxford cup by using a disposable injection needle, culturing for 24 hours in an incubator at 37 ℃, taking out (culturing propionibacterium acnes for 48 hours by using an anaerobic glove box), and accurately measuring the diameter of the effective inhibition zone of the test solution in each culture dish by using a caliper. Each sample was repeated 3 times.
Experimental groups: the acne treatment cream described herein; control group: blank control group (culture medium), negative control group (culture medium, bacterial suspension, sterile water), and positive control group (culture medium, bacterial suspension, erythromycin). Specifically, as shown in table 1, it can be seen from table 1 that the anti-acne emulsion produced by the present invention has a significant antibacterial effect, and has a certain inhibitory effect on staphylococcus aureus and propionibacterium acnes.
TABLE 1 anti-acne cream bacteriostatic effect
Example 8 efficacy evaluation
Testing an instrument: VISIA 7, ANTERA-3D, Tewameter TM300
The test period was 5 weeks, during which the volunteers used the test samples in the morning and evening of the full face, in the order of use: face wash, test sample, moisturizing milk.
Volunteers visited before (W0), 1 week after (W1), 2 weeks after (W2), 3 weeks after (W3), and 5 weeks after (W4) the use (W5). The face was cleaned with a facial cleanser and sat in an evaluation room test environment for 20min during which time no water or beverage was available. After sitting still, VISIA, ant-3D facial image acquisition and facial water loss rate (TEWL) test were performed on the face. And fill out the questionnaire.
The effective test population is 30, the age is 18-35 years, the face has skin damage, namely: stage I: acne alone; and II, stage: inflammatory papules; grade III: pustules.
And (3) testing environment: temperature (22 +/-1) DEG C and humidity (55 +/-5)%, and real-time dynamic monitoring is carried out.
The test results are summarized as table 2, and it can be seen from table 2 that indexes such as facial pores, facial protrusions, heme, TEWL and the like are reduced to a certain extent after the test population uses the acne-removing emulsion for 5 weeks, the volume and the area of the facial pores are reduced, the number of the facial pores is reduced, the volume of the facial protrusions is reduced, the affected area of the heme is reduced, and the TEWL is reduced; and after the use for 1 week and 2 weeks, each index is obviously reduced, and as the use time is prolonged, each index is continuously reduced, and after the use for about 4 weeks, the data have a stable trend.
TABLE 2 analysis of facial indices
The results of the survey questionnaire of the tested population show that: the acceptance degree of testers on the mildness and the acne removing effect of the test sample is high, and 95% of testers think that the test sample has an obvious inhibition effect on acne; 92% of the testers considered that the test sample had a better improvement effect on the skin; the 87% of the testers considered the test sample to be milder and non-irritating to the skin.
The combination of facial test data and questionnaire results shows that the product of the invention can significantly inhibit acne, improve damaged skin, and is non-irritating both when and after use.
The results show that the preparation method has simple flow and is easy for large-scale production; the preparation condition is mild, and the natural activity of the skin conditioner is not damaged; the produced acne-removing emulsion has obvious antibacterial effect, can obviously improve the damaged skin of acne patients, and is obviously superior to the prior art.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.
Claims (11)
1. The preparation method of the acne-removing emulsion is characterized by comprising the following steps:
step 1) mixing a solvent, a humectant, a penetration enhancer, borneol, a salvia miltiorrhiza extract and a alkanna tinctoria root extract according to a certain proportion, stirring and heating to prepare a water phase matrix;
step 2) mixing the humectant, the lubricant and the emulsifier according to a certain proportion, stirring and heating to prepare an oil phase matrix;
step 3) slowly adding the oil phase matrix into the water phase matrix, and homogenizing at a certain rotating speed; adding xanthan gum solution with the final concentration of 5% (w/w), and continuously stirring;
step 4), adding the aloe vera leaf extract and the humectant into the mixture after passing through a high-pressure homogenizer, and stirring and mixing the mixture uniformly;
step 5) adding an antimicrobial agent to the final emulsion.
2. The preparation method according to claim 1, wherein the step 1) is to heat the aqueous phase matrix to 60-100 ℃ with stirring and keep the temperature constant for 15-25 minutes.
3. The preparation method according to claim 1, wherein the step 2) is to heat the oil phase matrix to 60-100 ℃ with stirring and keep the temperature constant for 2-10 minutes.
4. The preparation method as claimed in claim 1, wherein the step 3) is to slowly add the oil phase matrix into the water phase matrix, and homogenize at 9500-11000rpm for 1-3 minutes; 5% xanthan gum solution was added and stirring was continued for 3-5 minutes at 12000-14000 rpm.
5. The preparation method according to claim 4, wherein the adding speed is 3-10kg/min, and the adding stirring speed is 45-55 rpm.
6. The method of claim 1, wherein step 4) is performed by a three-stage two-stage high pressure homogenizer at a pressure set at 300/30 bar.
7. The preparation method according to claim 1, wherein the temperature in step 4) is reduced to 30-50 ℃, and the aloe vera leaf extract and the humectant are added, stirred and mixed uniformly.
8. The method according to claim 1, further comprising a process of preparing an extract: soaking target Chinese medicinal materials in solvent; adding the wetted medicinal materials into a solvent for soaking for 24 hours; percolating the soaked Chinese medicinal materials at a percolation rate of 50-250 mL/min/kg; collecting percolate, vacuum concentrating and drying to obtain extract; wherein, the solvent is water, ethanol or a solution of the water and the ethanol mixed according to different proportions.
9. The method of claim 1, wherein the antibacterial agent is 0.1% (w/w) methylparaben.
10. The preparation method according to claim 1, wherein in step 1), the solvent in the aqueous phase matrix is water or ethanol, the humectant is 1, 3-propylene glycol or glycerin, the penetration enhancer is laurocapram, the humectant in the oil phase matrix is petrolatum, lanolin or sodium stearyl glutamate, the lubricant is polydimethylsiloxane, and the emulsifier is cetostearyl alcohol; wherein the final content of ethanol is 5% (w/w).
11. The method according to claim 1, wherein the humectant in the step 4) is 1, 2-ethanediol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010323892.4A CN111529440A (en) | 2020-04-22 | 2020-04-22 | Preparation method of acne-removing emulsion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010323892.4A CN111529440A (en) | 2020-04-22 | 2020-04-22 | Preparation method of acne-removing emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529440A true CN111529440A (en) | 2020-08-14 |
Family
ID=71969683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010323892.4A Pending CN111529440A (en) | 2020-04-22 | 2020-04-22 | Preparation method of acne-removing emulsion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529440A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101468070A (en) * | 2007-12-27 | 2009-07-01 | 天津天阜康生物技术发展有限公司 | Medicinal composition for treating acne and preparation method thereof |
CN104434685A (en) * | 2014-12-10 | 2015-03-25 | 唯美度科技(北京)有限公司 | Light facial cleanser and preparation method of light facial cleanser |
CN105816594A (en) * | 2016-04-06 | 2016-08-03 | 重庆市中药研究院 | Medicinal composition for treating acne as well as preparation method and application of medicinal composition |
-
2020
- 2020-04-22 CN CN202010323892.4A patent/CN111529440A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101468070A (en) * | 2007-12-27 | 2009-07-01 | 天津天阜康生物技术发展有限公司 | Medicinal composition for treating acne and preparation method thereof |
CN104434685A (en) * | 2014-12-10 | 2015-03-25 | 唯美度科技(北京)有限公司 | Light facial cleanser and preparation method of light facial cleanser |
CN105816594A (en) * | 2016-04-06 | 2016-08-03 | 重庆市中药研究院 | Medicinal composition for treating acne as well as preparation method and application of medicinal composition |
Non-Patent Citations (2)
Title |
---|
胡冬裴;: "中药内服外用治疗痤疮的疗效观察及机理初探" * |
陈美华;: "丹栀逍遥丸治疗肝气郁结型粉刺60例" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102406576B (en) | Prinsepia utilis Royle oil-containing functional skin care product and preparation method thereof | |
CN110585114A (en) | Bactericidal composition for regulating skin microbial flora and application thereof | |
CN113116755A (en) | Skin care composition for promoting penetration and preparation method and application thereof | |
CN113491646A (en) | Natural plant essential oil microemulsion as well as preparation method and application thereof | |
CN113413356A (en) | Peach tocol-based acne-removing composition and preparation method thereof | |
CN116370390A (en) | Multifunctional skin cleaning composition containing biosurfactant and preparation method and application thereof | |
CN112022895B (en) | Composition for skin barrier repair and preparation method thereof | |
CN106511218A (en) | Emulsion capable of removing acne | |
CN112870114A (en) | Natural moisturizing composition and preparation method thereof | |
CN112773733A (en) | Acne-removing composition and preparation method of emulsion thereof | |
CN109381375B (en) | Essential oil composition for scalp care and application | |
CN111529440A (en) | Preparation method of acne-removing emulsion | |
CN115054566B (en) | Scalp aging resisting composition and preparation method thereof | |
CN113350255B (en) | Low-irritation antibacterial cosmetic and preparation method thereof | |
CN1843398A (en) | Medicine possessing treating myopia function | |
CN109602676A (en) | A kind of combination and its preparation process of vegetable soda antiallergic element | |
CN115770209A (en) | Rod-shaped lithospermum ointment containing three-purple oil and preparation method thereof | |
CN115607476A (en) | Composition with moisturizing and antioxidant effects and application thereof | |
CN111821331A (en) | External gel for repelling mosquitoes, relieving itching and diminishing swelling and preparation method thereof | |
JP4295841B2 (en) | Antiallergic topical agent | |
CN109771313A (en) | A kind of anti-acne jelly and preparation method thereof | |
CN108853480A (en) | Hair growth composition, preparation method and applications | |
CN109172407B (en) | Application of high-molecular cationic polymer and skin care product prepared from high-molecular cationic polymer | |
CN111686179B (en) | Traditional Chinese medicine compound extract with acne removing and red blood streak removing effects and application thereof | |
CN113995701B (en) | Composition for removing acnes and acne marks as well as preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200814 |
|
WD01 | Invention patent application deemed withdrawn after publication |